{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:01:06Z","timestamp":1792342866661,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T35AG049685"],"award-info":[{"award-number":["T35AG049685"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["NEI P30EY026878"],"award-info":[{"award-number":["NEI P30EY026878"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00417-020-04892-5","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T05:38:37Z","timestamp":1597815517000},"page":"307-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Central geographic atrophy vs. neovascular age\u2013related macular degeneration: differences in longitudinal vision-related quality of life"],"prefix":"10.1007","volume":"259","author":[{"given":"Aneesha","family":"Ahluwalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangbo L.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian V.","family":"Del Priore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"4892_CR1","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2147\/opth.S45248","volume":"7","author":"M Yuzawa","year":"2013","unstructured":"Yuzawa M, Fujita K, Tanaka E, Wang EC (2013) Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice. Clin Ophthalmol (Auckland, NZ) 7:1325\u20131332. https:\/\/doi.org\/10.2147\/opth.S45248","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"10","key":"4892_CR2","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","volume":"36","author":"SR Sadda","year":"2016","unstructured":"Sadda SR, Chakravarthy U, Birch DG, Staurenghi G, Henry EC, Brittain C (2016) Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration. Retina 36(10):1806\u20131822. https:\/\/doi.org\/10.1097\/IAE.0000000000001283","journal-title":"Retina"},{"issue":"11","key":"4892_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (Chicago, Ill : 1960) 116(11):1496\u20131504","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"4","key":"4892_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/archopht.116.4.514","volume":"116","author":"RA Williams","year":"1998","unstructured":"Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI (1998) The psychosocial impact of macular degeneration. Arch Ophthalmol (Chicago, Ill : 1960) 116(4):514\u2013520. https:\/\/doi.org\/10.1001\/archopht.116.4.514","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"1","key":"4892_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ophtha.2004.06.036","volume":"112","author":"MT Cahill","year":"2005","unstructured":"Cahill MT, Banks AD, Stinnett SS, Toth CA (2005) Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112(1):152\u2013158. https:\/\/doi.org\/10.1016\/j.ophtha.2004.06.036","journal-title":"Ophthalmology"},{"issue":"1","key":"4892_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2004.02.011","volume":"138","author":"LM Dong","year":"2004","unstructured":"Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA (2004) Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol 138(1):91\u2013108. https:\/\/doi.org\/10.1016\/j.ajo.2004.02.011","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4892_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/archopht.121.4.531","volume":"121","author":"PH Miskala","year":"2003","unstructured":"Miskala PH, Hawkins BS, Mangione CM, Bass EB, Bressler NM, Dong LM, Marsh MJ, McCaffrey LD (2003) Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1. Arch Ophthalmol (Chicago, Ill: 1960) 121(4):531\u2013539. https:\/\/doi.org\/10.1001\/archopht.121.4.531","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"2","key":"4892_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/archopht.121.2.211","volume":"121","author":"TE Clemons","year":"2003","unstructured":"Clemons TE, Chew EY, Bressler SB, McBee W, Age-Related Eye Disease Study Research G (2003) National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol (Chicago, Ill: 1960) 121(2):211\u2013217. https:\/\/doi.org\/10.1001\/archopht.121.2.211","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"9","key":"4892_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1001\/archopht.123.9.1207","volume":"123","author":"AS Lindblad","year":"2005","unstructured":"Lindblad AS, Clemons TE (2005) Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch Ophthalmol (Chicago, Ill : 1960) 123(9):1207\u20131214. https:\/\/doi.org\/10.1001\/archopht.123.9.1207","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"5","key":"4892_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajo.2010.05.030","volume":"150","author":"AL Coleman","year":"2010","unstructured":"Coleman AL, Yu F, Ensrud KE, Stone KL, Cauley JA, Pedula KL, Hochberg MC, Mangione CM (2010) Impact of age-related macular degeneration on vision-specific quality of life: follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. Am J Ophthalmol 150(5):683\u2013691. https:\/\/doi.org\/10.1016\/j.ajo.2010.05.030","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4892_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati J, Fowler BJ (2012) Mechanisms of age-related macular degeneration. Neuron 75(1):26\u201339. https:\/\/doi.org\/10.1016\/j.neuron.2012.06.018","journal-title":"Neuron"},{"issue":"6","key":"4892_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.22608\/APO.2017262","volume":"6","author":"R Kandasamy","year":"2017","unstructured":"Kandasamy R, Wickremasinghe S, Guymer R (2017) New treatment modalities for geographic atrophy. Asia Pac J Ophthalmol (Phila) 6(6):508\u2013513. https:\/\/doi.org\/10.22608\/APO.2017262","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"4892_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/IAE.0000000000000036","volume":"34","author":"R Velez-Montoya","year":"2014","unstructured":"Velez-Montoya R, Oliver SC, Olson JL, Fine SL, Quiroz-Mercado H, Mandava N (2014) Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention. Retina 34(3):423\u2013441. https:\/\/doi.org\/10.1097\/IAE.0000000000000036","journal-title":"Retina"},{"key":"4892_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2018.03.006","volume":"190","author":"S Sivaprasad","year":"2018","unstructured":"Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, Dolan C, Silverman D (2018) Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the phase 2 Mahalo study. Am Jof Ophthalmol 190:1\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2018.03.006","journal-title":"Am Jof Ophthalmol"},{"issue":"4","key":"4892_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/archophthalmol.2009.58","volume":"127","author":"DB Rein","year":"2009","unstructured":"Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, Vision Health Cost-Effectiveness Study G (2009) Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol (Chicago, Ill : 1960) 127(4):533\u2013540. https:\/\/doi.org\/10.1001\/archophthalmol.2009.58","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"6","key":"4892_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","volume":"20","author":"G Age-Related Eye Disease Study Resea","year":"1999","unstructured":"Age-Related Eye Disease Study Research G (1999) The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials 20(6):573\u2013600","journal-title":"Control Clin Trials"},{"issue":"3","key":"4892_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/jamaophthalmol.2013.6636","volume":"132","author":"EY Chew","year":"2014","unstructured":"Chew EY, Clemons TE, Agr\u00f3n E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL 3rd (2014) Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA Ophthalmol 132(3):272\u2013277. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.6636","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"4892_CR18","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1167\/iovs.10-5645","volume":"52","author":"P Orr","year":"2011","unstructured":"Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, Fine JT, Bressler NM (2011) Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci 52(6):3354\u20133359. https:\/\/doi.org\/10.1167\/iovs.10-5645","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4892_CR19","unstructured":"National Center for Biotechnology Information (NCBI) database of Genotypes and Phenotypes (dbGaP) National Eye Institute (NEI) Age-Related Eye Disease Study (AREDS). dbGaP Study Accession: phs000001v3p1 2016. Bethesda: National Center for Biotechnology Information. https:\/\/www.ncbi.nlm.nih.gov\/projects\/gap\/cgi-bin\/study.cgi?study_id=phs000001.v3.p1. Accessed 15 Nov 2019"},{"issue":"11","key":"4892_CR20","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","volume":"123","author":"MD Davis","year":"2005","unstructured":"Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, Ferris FL, Bressler SB, Milton RC, Age-Related Eye Disease Study G (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (Chicago, Ill : 1960) 123(11):1484\u20131498. https:\/\/doi.org\/10.1001\/archopht.123.11.1484","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"11","key":"4892_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.ophtha.2017.04.026","volume":"124","author":"X Kong","year":"2017","unstructured":"Kong X, Strauss RW, Cideciyan AV, Michaelides M, Sahel JA, Munoz B, Ahmed M, Ervin AM, West SK, Cheetham JK, Scholl HPN, ProgStar Study G (2017) Visual acuity change over 12 months in the prospective progression of atrophy secondary to stargardt disease (ProgStar) study: ProgStar Report Number 6. Ophthalmology 124(11):1640\u20131651. https:\/\/doi.org\/10.1016\/j.ophtha.2017.04.026","journal-title":"Ophthalmology"},{"issue":"2","key":"4892_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1167\/iovs.05-0381","volume":"47","author":"LJ Davis","year":"2006","unstructured":"Davis LJ, Schechtman KB, Wilson BS, Rosenstiel CE, Riley CH, Libassi DP, Gundel RE, Rosenberg L, Gordon MO, Zadnik K, Collaborative longitudinal evaluation of keratoconus study G (2006) Longitudinal changes in visual acuity in keratoconus. Invest Ophthalmol Vis Sci 47(2):489\u2013500. https:\/\/doi.org\/10.1167\/iovs.05-0381","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4892_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.61.1.2","volume":"61","author":"LL Shen","year":"2020","unstructured":"Shen LL, Sun M, Khetpal S, Grossetta Nardini HK, Del Priore LV (2020) Topographic variation of the growth rate of geographic atrophy in nonexudative age-related macular degeneration: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci 61(1):2. https:\/\/doi.org\/10.1167\/iovs.61.1.2","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4892_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"TY Wong","year":"2008","unstructured":"Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115(1):116\u2013126. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.008","journal-title":"Ophthalmology"},{"issue":"3","key":"4892_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/B:SOCI.0000003801.89195.bc","volume":"65","author":"M Eid","year":"2004","unstructured":"Eid M, Diener E (2004) Global judgments of subective well-being: situational variability and long-term stability. Soc Indic Res 65(3):245\u2013277","journal-title":"Soc Indic Res"},{"key":"4892_CR26","doi-asserted-by":"publisher","first-page":"233372141880160","DOI":"10.1177\/2333721418801601","volume":"4","author":"AC Schippert","year":"2018","unstructured":"Schippert AC, Jelin E, Moe MC, Heiberg T, Grov EK (2018) The impact of age-related macular degeneration on quality of life and its association with demographic data: results from the NEI VFQ-25 questionnaire in a Norwegian Population. Gerontol Geriatr Med 4:2333721418801601. https:\/\/doi.org\/10.1177\/2333721418801601","journal-title":"Gerontol Geriatr Med"},{"issue":"6","key":"4892_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2016.1181192","volume":"32","author":"I Chatziralli","year":"2017","unstructured":"Chatziralli I, Mitropoulos P, Parikakis E, Niakas D, Labiris G (2017) Risk factors for poor quality of life among patients with age-related macular degeneration. Semin Ophthalmol 32(6):772\u2013780. https:\/\/doi.org\/10.1080\/08820538.2016.1181192","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"4892_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ajo.2005.03.078","volume":"140","author":"BA Fink","year":"2005","unstructured":"Fink BA, Wagner H, Steger-May K, Rosenstiel C, Roediger T, McMahon TT, Gordon MO, Zadnik K (2005) Differences in keratoconus as a function of gender. Am J Ophthalmol 140(3):459\u2013468. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.078","journal-title":"Am J Ophthalmol"},{"key":"4892_CR29","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3389\/fpsyg.2018.01872","volume":"9","author":"DE Sorman","year":"2018","unstructured":"Sorman DE, Ljungberg JK, Ronnlund M (2018) Reading habits among older adults in relation to level and 15-year changes in verbal fluency and episodic recall. Front Psychol 9:1872. https:\/\/doi.org\/10.3389\/fpsyg.2018.01872","journal-title":"Front Psychol"},{"issue":"9","key":"4892_CR30","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1002\/jcp.26486","volume":"233","author":"C Astarita","year":"2018","unstructured":"Astarita C, D'Angelo-Maansson B, Massaro-Giordano M, Alba MP, Boffo S, Macchi I, Giordano A, Macaluso M (2018) Effect of sex steroid hormone fluctuations in the pathophysiology of male-retinal pigment epithelial cells. J Cell Physiol 233(9):6965\u20136974. https:\/\/doi.org\/10.1002\/jcp.26486","journal-title":"J Cell Physiol"},{"key":"4892_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.maturitas.2015.10.005","volume":"83","author":"M Zetterberg","year":"2016","unstructured":"Zetterberg M (2016) Age-related eye disease and gender. Maturitas 83:19\u201326. https:\/\/doi.org\/10.1016\/j.maturitas.2015.10.005","journal-title":"Maturitas"},{"key":"4892_CR32","doi-asserted-by":"publisher","unstructured":"Tufail A, Margaron P, Guerin T, Larsen M (2019) Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINA. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313682","DOI":"10.1136\/bjophthalmol-2018-313682"},{"issue":"10","key":"4892_CR33","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1167\/iovs.08-1749","volume":"49","author":"TE Clemons","year":"2008","unstructured":"Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa M, Harrington MW, Macular Telangiectasia Research G (2008) The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project. Invest Ophthalmol Vis Sci 49(10):4340\u20134346. https:\/\/doi.org\/10.1167\/iovs.08-1749","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4892_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ophtha.2009.09.002","volume":"117","author":"NM Bressler","year":"2010","unstructured":"Bressler NM, Chang TS, Suner IJ, Fine JT, Dolan CM, Ward J, Ianchulev T, Marina GAR (2010) Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology 117(4):747\u2013756 e744. https:\/\/doi.org\/10.1016\/j.ophtha.2009.09.002","journal-title":"Ophthalmology"},{"issue":"1","key":"4892_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40942-017-0071-1","volume":"3","author":"JA Ram\u00edrez Estudillo","year":"2017","unstructured":"Ram\u00edrez Estudillo JA, Le\u00f3n Higuera MI, Rojas Ju\u00e1rez S, Ordaz Vera ML, Pablo Santana Y, Celis Suazo B (2017) Visual rehabilitation via microperimetry in patients with geographic atrophy: a pilot study. Int J Retina Vitreous 3(1):21. https:\/\/doi.org\/10.1186\/s40942-017-0071-1","journal-title":"Int J Retina Vitreous"},{"issue":"16","key":"4892_CR36","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/s0042-6989(03)00219-0","volume":"43","author":"UL Nilsson","year":"2003","unstructured":"Nilsson UL, Frennesson C, Nilsson SE (2003) Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope. Vision Res 43(16):1777\u20131787. https:\/\/doi.org\/10.1016\/s0042-6989(03)00219-0","journal-title":"Vision Res"},{"issue":"4","key":"4892_CR37","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1167\/iovs.06-0610","volume":"48","author":"EL Lamoureux","year":"2007","unstructured":"Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE (2007) The effectiveness of low-vision rehabilitation on participation in daily living and quality of life. Invest Ophthalmol Vis Sci 48(4):1476\u20131482. https:\/\/doi.org\/10.1167\/iovs.06-0610","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4892_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12955-017-0732-7","volume":"15","author":"S Nickels","year":"2017","unstructured":"Nickels S, Schuster AK, Singer S, Wild PS, Laubert-Reh D, Schulz A, Finger RP, Michal M, Beutel ME, M\u00fcnzel T, Lackner KJ, Pfeiffer N (2017) The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25) - reference data from the German population-based Gutenberg Health Study (GHS). Health Qual Life Outcomes 15(1):156. https:\/\/doi.org\/10.1186\/s12955-017-0732-7","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"4892_CR39","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ophtha.2015.11.028","volume":"123","author":"HP van der Aa","year":"2016","unstructured":"van der Aa HP, Xie J, Rees G, Fenwick E, Holloway EE, van Rens GH, van Nispen RM (2016) Validated prediction model of depression in visually impaired older adults. Ophthalmology 123(5):1164\u20131166. https:\/\/doi.org\/10.1016\/j.ophtha.2015.11.028","journal-title":"Ophthalmology"},{"issue":"3","key":"4892_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0042-6989(00)00249-2","volume":"41","author":"RW Massof","year":"2001","unstructured":"Massof RW, Fletcher DC (2001) Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res 41(3):397\u2013413. https:\/\/doi.org\/10.1016\/s0042-6989(00)00249-2","journal-title":"Vision Res"},{"issue":"2","key":"4892_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1167\/iovs.09-3766","volume":"51","author":"DA Revicki","year":"2010","unstructured":"Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P (2010) Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 51(2):712\u2013717. https:\/\/doi.org\/10.1167\/iovs.09-3766","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4892_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2415-6-24","volume":"6","author":"CG Owen","year":"2006","unstructured":"Owen CG, Rudnicka AR, Smeeth L, Evans JR, Wormald RP, Fletcher AE (2006) Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population? BMC Ophthalmol 6:24. https:\/\/doi.org\/10.1186\/1471-2415-6-24","journal-title":"BMC Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04892-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04892-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04892-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T23:34:51Z","timestamp":1629329691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04892-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4892"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04892-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflicting relationship exists for any author. Lucian V. Del Priore serves as a consultant for Astellas Institute for Regenerative Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was exempted by the Yale Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All study analyses were performed using <i>R 3.6.0<\/i> (R Foundation for Statistical Computing, Vienna, Austria).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The sponsors or funding organizations had no role in the design or conduct of this research.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}